A clinician displays the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir vial, during the first phase of the national rollout, at the Riruta Health Centre in Nairobi on February 26, 2026.

Yusuf Omar, director of Omar Motor Den.